Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
25°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Syndax Pharma
(NQ:
SNDX
)
20.49
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1
Open
20.49
Bid (Size)
19.94 (1)
Ask (Size)
23.00 (4)
Prev. Close
20.49
Today's Range
20.49 - 20.49
52wk Range
11.21 - 25.34
Shares Outstanding
69,484,053
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Syndax Pharmaceuticals: Q4 Earnings Insights
February 27, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Performance
YTD
-6.27%
-6.27%
1 Month
-7.79%
-7.79%
3 Month
-3.85%
-3.85%
6 Month
+76.49%
+76.49%
1 Year
-1.49%
-1.49%
More News
Read More
Earnings Preview: Syndax Pharmaceuticals
February 26, 2024
Via
Benzinga
Is The Stock Market Ready To Plunge? The Warning Signs Are Here...
February 21, 2024
Via
Talk Markets
What's Going On With Leukemia-Focused Syndax Pharmaceuticals Stock Today?
December 11, 2023
Via
Benzinga
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease
December 10, 2023
From
Incyte and Syndax Pharmaceuticals
Via
Business Wire
Earnings Outlook For Syndax Pharmaceuticals
November 01, 2023
Via
Benzinga
Analyst Ratings for Syndax Pharmaceuticals
October 17, 2023
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 09, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023
October 11, 2023
Via
Benzinga
What's Going On With Syndax Pharmaceuticals Stock Monday?
October 02, 2023
Via
Benzinga
Citigroup Maintains Buy Rating for Syndax Pharmaceuticals: Here's What You Need To Know
July 26, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Syndax Pharmaceuticals
July 25, 2023
Via
Benzinga
Earnings Scheduled For November 2, 2023
November 02, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 05, 2023
Via
Benzinga
Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket
October 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 29, 2023
Via
Benzinga
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 29, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 29, 2023
Via
Benzinga
Vail Resorts, Carnival, Opera And Other Big Stocks Moving Lower On Friday
September 29, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
September 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
July 27, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.